Abbott/Alza
Executive Summary
New merger vote will likely not occur until next year. Alza shareholders had originally approved the merger Sept. 21. On Sept. 28, Abbott announced it was in discussions with FDA on a consent decree for its diagnostics manufacturing business, which it has since signed with the agency (1"The Pink Sheet" Oct. 4, p. 14). Alza and Abbott have agreed to a second shareholder vote in light of the decline in the merger's value since the consent decree process began